BRIDGEWAY CAPITAL MANAGEMENT, LLC - PLURISTEM THERAPEUTICS INC ownership

PLURISTEM THERAPEUTICS INC's ticker is PSTI and the CUSIP is 72940R300. A total of 64 filers reported holding PLURISTEM THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.73 and the average weighting 0.0%.

Quarter-by-quarter ownership
BRIDGEWAY CAPITAL MANAGEMENT, LLC ownership history of PLURISTEM THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$138,000
-4.8%
112,600
+60.9%
0.00%0.0%
Q1 2022$145,000
-17.1%
70,000
-41.7%
0.00%0.0%
Q4 2021$175,000
-45.0%
120,0000.0%0.00%
-50.0%
Q3 2021$318,000
-58.8%
120,000
-38.5%
0.01%
-57.1%
Q2 2021$772,000
+391.7%
195,000
+490.9%
0.01%
+366.7%
Q1 2021$157,00033,0000.00%
Other shareholders
PLURISTEM THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
NIA IMPACT ADVISORS, LLC 837,898$1,734,0000.84%
Green Alpha Advisors, LLC 78,159$162,0000.11%
Values First Advisors, Inc. 49,485$102,0000.06%
SHELTON CAPITAL MANAGEMENT 128,532$266,0000.01%
Archford Capital Strategies, LLC 13,091$29,0000.01%
MEITAV INVESTMENT HOUSE LTD 167,593$347,0000.01%
Halpern Financial, Inc. 5,800$12,0060.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 70,000$145,0000.00%
TOWNSQUARE CAPITAL LLC 23,938$50,0000.00%
Newbridge Financial Services Group, Inc. 1,200$2,0000.00%
View complete list of PLURISTEM THERAPEUTICS INC shareholders